[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.112.64. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
October 21, 1950

MONOCYTIC LEUKEMIA TREATED WITH PITUITARY ADRENOCORTICOTROPIC HORMONE (ACTH)

Author Affiliations

Oakland, Calif.

From the Services of Medicine and Pathology of the Samuel Merritt Hospital and the Institute for Metabolic Research of the Highland-Alameda County Hospital.

JAMA. 1950;144(8):617-618. doi:10.1001/jama.1950.62920080003006b
Abstract

Reports of the treatment of patients who have monocytic leukemia with pituitary adrenocorticotropic hormone (ACTH) or cortisone indicate a lack of favorable response or an actual acceleration of the progression of the disease.1 In this report we summarize the clinical and hematological data for a patient with acute monocytic leukemia who has shown impressive improvement during pituitary adrenocorticotropic hormone therapy.

REPORT OF CASE  A woman aged 56 years was examined by one of us (H. R.) in September 1949 because she had an acute respiratory infection. She gave a history of some previous fatigue and some loosening of the teeth. Examination of the blood disclosed 3,350,000 red blood cells, 9.2 Gm. hemoglobin and 6,100 white blood cells with 24 per cent neutrophils (11 per cent banded), 4 per cent eosinophils, 1 per cent basophils, 54 per cent "lymphocytes" and 16 per cent monocytes. The platelets were normal in appearance.

First Page Preview View Large
First page PDF preview
First page PDF preview
×